Royal Bank of Canada’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $795K | Buy |
27,126
+26,320
| +3,266% | +$771K | ﹤0.01% | 3779 |
|
|
2025
Q1 | $21K | Sell |
806
-924
| -53% | -$24.1K | ﹤0.01% | 5535 |
|
|
2024
Q4 | $50K | Buy |
1,730
+440
| +34% | +$12.7K | ﹤0.01% | 5215 |
|
|
2024
Q3 | $30K | Sell |
1,290
-52
| -4% | -$1.21K | ﹤0.01% | 5480 |
|
|
2024
Q2 | $23K | Buy |
1,342
+1,249
| +1,343% | +$21.4K | ﹤0.01% | 5632 |
|
|
2024
Q1 | $2K | Sell |
93
-1,003
| -92% | -$21.6K | ﹤0.01% | 6267 |
|
|
2023
Q4 | $20K | Buy |
1,096
+139
| +15% | +$2.54K | ﹤0.01% | 5778 |
|
|
2023
Q3 | $17K | Sell |
957
-203
| -18% | -$3.61K | ﹤0.01% | 5749 |
|
|
2023
Q2 | $21K | Buy |
1,160
+1,159
| +115,900% | +$21K | ﹤0.01% | 5738 |
|
|
2023
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 6994 |
|
|
2022
Q4 | $0 | Buy |
+1
| New | – | ﹤0.01% | 7224 |
|
|
2022
Q2 | – | Sell |
-259
| Closed | -$9K | – | 7187 |
|
|
2022
Q1 | $9K | Sell |
259
-193
| -43% | -$6.71K | ﹤0.01% | 6525 |
|
|
2021
Q4 | $39K | Buy |
452
+178
| +65% | +$15.4K | ﹤0.01% | 5981 |
|
|
2021
Q3 | $32K | Buy |
274
+269
| +5,380% | +$31.4K | ﹤0.01% | 5908 |
|
|
2021
Q2 | $1K | Buy |
+5
| New | +$1K | ﹤0.01% | 6847 |
|